Metrolinx awards Aecon-led consortium $1.2bn Toronto transit contract

By zaymalz malz
Share

Metrolinx, the transport agency representing the Ontario and Toronto area, has awarded a new $1.2bn contract to the Aecon-led Mosaic Transit Group for the construction of the Finch West Light Rail Transit project.

The light-rail transit line, stretching 11km, will run through northwest Toronto linking the Finch West subway station with Humber college, including 16 different stops throughout the route.

See also:

“Aecon continues to demonstrate proven capabilities to secure and deliver large-scale, complex infrastructure projects,” said John Beck, President and Chief Executive Officer, Aecon Group. “We look forward to working with Metrolinx, Infrastructure Ontario and our partners to execute this world-class project.”

Each of Aecon, ACS Infrastructure Canada and CRH Canada making up the Mosaic Transit Group will retain a 33.3% stake in the construction of the project, whilst Aecon and ACS Infrastructure will each own 50% equity in the 30-year maintenance agreement.

“The Finch West light rail transit will be a significant addition to Toronto’s transit system and Aecon is pleased to play a key role in connecting communities across the Greater Toronto Area,” Beck continued.

It is forecast that construction of the project will begin in Q2 2018, with completion set for 2021.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy